Status:
UNKNOWN
Collaborative Network for Generating Scientific Evidence in COVID-19 For the Unified Health System in Brazil - RECOVER SUS-BRASIL
Lead Sponsor:
Evandro Chagas National Institute of Infectious Disease
Collaborating Sponsors:
Hospital Universitario Pedro Ernesto
Universidade Federal do Rio de Janeiro
Conditions:
Covid19
Hospitalization
Eligibility:
All Genders
18+ years
Brief Summary
The RECOVER SUS-BRASIL network, made up of excellent academic and research institutions, was formed in response to the emergence of unprecedented public health related to SARS-CoV-2. The Network's obj...
Detailed Description
Study 1 procedures are clinical and sociodemographic data collected through interview at admission and results of complementary exams performed during hospitalization. Data will be collected during th...
Eligibility Criteria
Inclusion
- Adults aged 18 years. Hospitalized for suspicious signs and symptoms of COVID-19 infection by the medical care team or confirmed by laboratory tests such as RT-PCR or rapid tests.
Exclusion
- Patient or family member refusal
Key Trial Info
Start Date :
July 25 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 25 2022
Estimated Enrollment :
3500 Patients enrolled
Trial Details
Trial ID
NCT04807699
Start Date
July 25 2020
End Date
March 25 2022
Last Update
March 19 2021
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital São José de Doenças Infecciosas - HSJ / Secretaria de Saúde Fortaleza
Fortaleza, Ceará, Brazil, 60455-610
2
Hospital Couto Maia/SES/BA
Salvador, Estado de Bahia, Brazil, 41332-150
3
Universidade Federal de Minas Gerais
Belo Horizonte, Minas Gerais, Brazil, 31270-901
4
Hospital dos Servidores do Estado/RJ
Rio de Janeiro, Rio de Janeiro, Brazil, 20221-161